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1. INTRODUCTION 
Important similarities between D-galactos- 
amine (GaIN)-mediated hepatocellular necrosis 
Hepatocytes Mitochondria 
and viral hepatitis have been emphasized [l]. The 
necrosis induced by GaIN is however accom- 
panied by hepatic triacylglycerol (TAG) accumu- 
lation [2], an association not present in human 
viral hepatitis. 
as 3 h after a single dose of GaIN. Having con- 
firmed that no increase in the serum FFA level is 
apparent at this stage of intoxication, this pre- 
liminary report was devoted to the study of the 
rate of fatty acid oxidation in isolated hepatocytes 
and mitochondria from GaIN treated rats. 
Koff et al. [3] first reported data suggesting that 
impaired hepatic lipoprotein release, presumably 
due to inhibition of synthesis of the protein moiety 
of very low density lipoproteins, is the mechanism 
of the GaIN-induced fatty liver. In further studies, 
in which a lower GaIN dose was used, Sabesin and 
Koff [4], observed, in the absence of any necrosis, 
the development of steatosis which was considered 
by the authors to result from an increased free fat- 
ty acid (FFA) influx rather than to an inhibition of 
TAG release. This hypothesis was further sup- 
ported by Katterman and Sirowej (51 who reported 
that the plasma FFA level was increased 24 and 
48 h after the intraperitoneal injection of GaIN. 
However, as no increase in plasma FFA was ob- 
served by these authors 12 h after GaIN admin- 
istration, and since TAG accumulation had al- 
ready occurred 4 h after GaIN administration, it 
seems highly unlikely that an increased FFA influx 
may play a major role in the development of the 
GaIN-induced fatty liver. 
The results show (i) that palmitate but not oc- 
tanoate oxidation was markedly depressed in 
hepatocytes from GaIN treated rats, and (ii) that 
palmitoyl CoA but not palmitoyl L-carnitine ox- 
idation in isolated mitochondria was affected. 
These data indicate therefore that GaIN admin- 
istration impairs the rate of fatty acid oxidation in 
the liver, and suggest hat this action results from a 
disturbance located at the carnitine palmitoyl- 
transferase I level. 
2. MATERIALS AND METHODS 
Collagenase from Clostridium histolyticum 
(Type IV), D( +) galactosamine-HCl, palmitoyl 
L-camitine-HCl, L-camitine and bovine serum al- 
bumin (fatty acid free-fraction V) were purchased 
from Sigma Chemical Co., [ I-t4C]octanoic acid 
sodium salt (spec. act. 30 mCi/mmol) and [U-mC]- 
palmitic acid (spec. act. 403 mCi/mmol) from 
Amersham. All other reagents were of analytical 
grade or of the highest purity available (Sigma, 
Merck or Fluka). 
The purpose of the present study was to estab- 
lish the factor(s) responsible for the TAG ac- 
cumulation which is observed in rat liver as early 
Male Wistar rats (C.E.R.J., F-53680) weighing 
200-240 g were kept at 20-22°C with a photo- 
period of 12D-12N. They were starved overnight 
before the experiments and given water ad libitum. 
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At 07:30 h D-galactosamine-HCl (neutralized at 
pH 7.4 with 2 N NaOH) was administered [278 PM 
(60 mg)/lOO g body wt] intraperitoneally, control 
rats receiving an equal volume of saline. 
Serum FFA were determined after Duncombe 
et al. [6] and aspartate aminotransferase (ASAT) 
(EC 2.6.1.1) activity according to Ceriotti [7] in 
blood collected after decapitation. Liver was 
quickly excised after decapitation and TAG deter- 
mined by the method of Eggstein et al. [8]. 
mental conditions. The reaction was stopped by re- 
frigeration at 4°C and by adding 110 pmol non-la- 
belled fatty acid as an albumin complex; samples 
were immediately centrifuged (500 x g for 2 min), 
hepatocytes in the pellets were rinsed twice in 
Krebs-Ringer buffer. The pellets were resus- 
pended in a final volume of 1 ml and 0.1 ml ali- 
quots were counted in scintillation vials containing 
10 ml of scintillation 299 TM (Packard). 
For the preparation of isolated hepatocytes the 
animals were anesthetized by intraperitoneal injec- 
tion of 50 mg sodium pentobarbital/ 100 g body wt 
and hepatocytes were isolated by collagenase per- 
fusion [9] in a Krebs-Ringer bicarbonate buffer 
(pH 7.4) gassed with 02 : CO1 (95 : 5). Integrity of 
hepatocytes from both control and treated rats was 
routinely assessed by measuring lactate dehydro- 
genase release into the medium [lo] and by cell 
membrane refractivity under phase-contrast 
microscopy. The viability of preparations from 
control and GaIN treated animals remained iden- 
tical and was usually 94-96%. Suspensions were 
diluted in the same buffer supplemented with de- 
fatted albumin (final concentration: 1%) in order 
to obtain 5-6 x 106 cells/ml corresponding to 
5-6 mg protein/ml. 
For the isolation of mitochondria, livers from 
treated and control animals were perfused with a 
saline solution at 4°C during 5 min. Liver mito- 
chondria were prepared by the method of Beattie 
[ 131. The fluffy layer was discarded, and the mito- 
chondrial pellet washed three times in 0.25 M 
sucrose at 4°C. The pellet was finally resuspended 
in the same medium at a protein concentration of 
50-75 mg/ml (protein was determined after [ 141). 
Mitochondrial respiration was measured as pre- 
viously described [ 151 at 25°C using a Gilson oxy- 
graph equipped with a Clark oxygen electrode. 
Statistical significance of results was assessed 
using Student’s paired t-test. 
3. RESULTS 
For the determination of palmitate or octanoate 
oxidation, 2 ml aliquots of this hepatocyte suspen- 
sion were incubated under 02 : CO2 (95 : 5) at 
37°C in 25 ml Erlenmeyer flasks provided with 
center wells equipped with a folded filter (What- 
man GF/A) impregnated with 0.1 ml 2 N KOH. 
The flasks were shaken in an incubator shaker 
(New Brunswick Scientific Co.) at 100 rev./min. 
After a preincubation period (10 min), 0.1 ml of 
the amino acid mixture suggested for energetic 
supply by Seglen [ 1 l] and labelled precursors (0.1 
ml) were added to the hepatocyte suspension. 
These labelled precursors consisted of 0.5 @i/ 1.1 
pmol palmitate or octanoate. 30 min after the addi- 
tion of precursors l4CO2 production was deter- 
mined according to Capuzzi et al. [ 121. All assays 
were triplicated. 
As seen in table 1, a significant increase of liver 
TAG is apparent 3 h after administration of GaIN. 
At this time no modification in the serum ASAT 
activity is apparent; the serum FFA level is also 
unimpaired. 
Hepatocytes isolated from rats at the same stage 
of GaIN intoxication and incubated with [l%]pal- 
mitate show (table 2) a 52% inhibition in 14CO2 
production, inhibition which is not prevented 
when 1 mM L-carnitine is added to the medium. 
t4C02 production from [l%]octanoate is unim- 
paired in the same conditions. 
No disturbance in the intracellular incorpora- 
tion of the label is apparent in hepatocytes isolated 
from GaIN treated rats incubated 30 min either 
with labelled palmitate [control: 3770 + 272 cpm . 
lo6 cells- I (n = 5); treated: 3646 2 353 (n = 5)] 
or labelled octanoate (data not shown). 
For the determination of the intracellular t4C Mitochondria from GaIN treated rats show no 
incorporation from labelled fatty acid, the hepato- abnormalities in the respiration rate with palmitoyl 
cyte suspension was incubated during 30 min. in L-carnitine as a substrate while oxidation rate of 
nalgene Erlenmeyer flasks under the same experi- palmitoyl CoA is significantly decreased (-35%). 
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Table 1 
Hepatic triacylglycerol level, serum free fatty acid concentration and aspartate 
aminotransferase activity 3 h after D-galactosamine administration 
Liver tag Blood serum 
pmol/g wt wt pmol/liver FFA ASAT 
mEq/l U/l 
Control 85820.42 49.1322.90 0.616 + 0.025 87.2 f 12.3 
Treated 11.23 + 0.22a 72.16+4.17a 0.676 f 0.05Ob 94.8 + 10.3b 
a P <0.001; b P >0.05 
Experiments were performed as described in the text. Each value is the mean + SEM 
of 8 expt 
Table 2 
Formation of t4CO2 from [U-t%]palmitate and [I-t%]octanoate by hepatocytes from 
D-galactosamine treated rats 
t4C-Labelled fatty acid Control Treated 
Palmitate 23lk 12 111+17a 
+ 1mM L-carnitine 226211 112+ 4a 
Octanoate 1152 17 108?~25~ 
a P <O.OOl; b P >0.05 
The cells were preincubated for 10 min in Krebs-Ringer bicarbonate buffer (pH 7.4) 
containing 1% defatted albumin and incubated during 30 min in the presence of 
0.5 mM [U-t’%]palmitate or 0.5 mM [I-t%]octanoate. Production of t4C02 is ex- 
pressed as cpm . 106 cells- 1. The results are mean values f SEM of 4 to 6 triplicate 
experiments 
Table 3 
Effect of D-galactosamine administration on palmitoyl L-carnitine and palmitoyl- 
CoA oxidation 
Substrates Animals 02 consumption (nmol. min -l . mg protein -I) 
State 4 State 3 
None 
Control 9.020.9 (5) 
Treated 10.7 If: 0.9 (5) 
Palmitoyl L-carnitine Control 15.62 1.2 (6) 37.2 4 2.7 (6) 
(0.025 mM) Treated 16.9 f 1.7 (6) 41.522.6 (6) 
Paimitoyl-CoA 
(0.025 mM) 
Control 12.1+0.7 (3) 
+ L-carnitine 
(2 mM) 
Treated 11.8+1.2(3) 
26.6 k 0.6 (3) 
17.4* 1.0 (3)a 
a P <O.OOl 
Oxidation rate was measured by polarography in isolated mitochondria from fasted 
rats. The results are mean values 5 SEM with the number of observations in 
parentheses 
269 
Volume 145, number 2 FEBSLETTERS August 1982 
4. DISCUSSION 
The present data show that the intraperitoneal 
administration of a single dose of 0.6 g GaIN per 
kg body wt results in an accumulation of liver 
TAG which is apparent at a stage where the ab- 
sence of increase in the serum ASAT level suggests 
the absence of liver necrosis. At the same time, the 
serum FFA level is not increased suggesting that 
increased peripheral lipolysis resulting in en- 
hanced blood FFA supply to the liver is not a pre- 
requisite for fatty liver induction by GaIN. 
The drastic decrease in palmitate oxidation to 
C@ found in hepatocytes isolated at this stage of 
intoxication suggests that an impairment in liver 
fatty acid oxidation may play an essential role in 
the induction of liver TAG accumulation following 
GaIN administration. 
Contrary to the results concerning palmitate, no 
inhibition was found in the oxidation of octanoate. 
Therefore, decreased CO2 production from palmi- 
tate in treated rats does not appear to be the result 
of endogenous dilution of the fatty acid pool. 
Octanoate, a short-chain fatty acid which can 
enter the mitochondria without the intervention of 
carnitine acyltransferases [ 161. This finding shows 
that the disturbance responsible for defective pal- 
mitate oxidation is localized at a level which pre- 
cedes /?-oxidation and which shows a specificity 
with respect o the fatty acid substrate, rather than 
at the P-oxidation level and/or the subsequent ri- 
carboxylic acid cycle. 
The results obtained when studying palmitoyl L- 
camitine oxidation in mitochondria isolated from 
D-GaIN treated rats confirm the absence of distur- 
bances in these mitochondrial processes. They sug- 
gest furthermore that the camitine palmitoyltrans- 
ferase II localized on the inner mitochondrial 
membrane is also unaffected. The total intracellu- 
lar radioactivity found after incubation with 
[tV]palmitate is unimpaired in hepatocytes iso- 
lated from such animals makes it unlikely that 
GaIN treatment affects primarily either palmitate 
uptake into the hepatocytes. Since palmitoyl-CoA 
oxidation is impaired by D-GaIN administration 
in isolated mitochondria, it is likely that GaIN acts 
mainly at the level of carnitine palmitoyltrans- 
ferase I, which catalyses the conversion of palmi- 
toyl-CoA to palmitoylcarnitine outside the mito- 
chondrial permeability barrier for acylCoA. A 
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decrease in the carnitine cell content is apparently 
not involved, as addition of camitine to the medi- 
um does not prevent the inhibition of palmitate 
oxidation in hepatocytes from GaIN-treated rats. 
Further research is in progress to ascertain whether 
GaIN administration affects directly carnitine pal- 
mitoyltransferase I activity or acts on this enzyme 
through changes in the concentration of malonyl- 
CoA, the effector of the transferase [ 161. 
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